Sotera Health Company (SHC) Earnings History
Annual and quarterly earnings data from 2018 to 2025
Loading earnings history...
SHC EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
SHC Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 55.5% | 33.8% | 6.7% |
| 2024 | 54.7% | 27.0% | 4.0% |
| 2023 | 55.0% | 26.4% | 4.9% |
| 2022 | 55.5% | 24.7% | -23.3% |
| 2021 | 55.7% | 27.6% | 12.5% |
Download Data
Export SHC earnings history in CSV or JSON format
Free sign-in required to download data
Sotera Health Company (SHC) Earnings Overview
As of May 8, 2026, Sotera Health Company (SHC) reported trailing twelve-month net income of $118M, reflecting +68.8% year-over-year growth. The company earned $0.41 per diluted share over the past four quarters, with a net profit margin of 6.7%.
Looking at the long-term picture, SHC's historical earnings data spans multiple years. The company achieved its highest annual net income of $117M in fiscal 2021.
Sotera Health Company maintains positive profitability with a gross margin of 55.5%, operating margin of 33.8%, and net margin of 6.7%. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including STRL ($347M net income, 11.7% margin), ICLR ($599M net income, 9.6% margin), CRL (-$185M net income, -3.6% margin), SHC has room to improve margins relative to the peer group. Compare SHC vs STRL →
SHC Earnings vs Peers
Earnings metrics vs comparable public companies
SHC Historical Earnings Data (2018–2025)
8 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $78M | +75.6% | $393M | $0.27 | 6.7% | 33.8% |
| 2024 | $44M | -13.6% | $298M | $0.16 | 4.0% | 27.0% |
| 2023 | $51M | +122.0% | $277M | $0.18 | 4.9% | 26.4% |
| 2022 | -$234M | -299.8% | $248M | $-0.83 | -23.3% | 24.7% |
| 2021 | $117M | +402.7% | $257M | $0.41 | 12.5% | 27.6% |
| 2020 | -$39M | -85.2% | $206M | $-0.14 | -4.7% | 25.2% |
| 2019 | -$21M | -255.2% | $184M | $-0.07 | -2.7% | 23.6% |
| 2018 | -$6M | - | $81M | $-0.02 | -0.8% | 10.8% |
See SHC's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs SHC Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare SHC vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonSHC — Frequently Asked Questions
Quick answers to the most common questions about buying SHC stock.
Is SHC growing earnings?
SHC EPS is $0.41, with earnings growth accelerating to +68.8%. This exceeds the 5-year CAGR of N/A. TTM net income reached $118M.
What are SHC's profit margins?
Sotera Health Company net margin is +6.7%, with operating margin at +33.8%. Margins sit within typical range for the sector.
How consistent are SHC's earnings?
SHC earnings data spans 2018-2025. The accelerating earnings trend is +68.8% YoY. Historical data enables comparison across business cycles.